Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Pascal Mettens"'
Autor:
Clarisse Lorin, Yannick Vanloubbeeck, Sébastien Baudart, Michaël Ska, Babak Bayat, Geoffroy Brauers, Géraldine Clarinval, Marie-Noëlle Donner, Martine Marchand, Marguerite Koutsoukos, Pascal Mettens, Joe Cohen, Gerald Voss
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122835 (2015)
HIV-1-specific CD4+ and CD8+ T lymphocytes are important for HIV-1 replication control. F4/AS01 consists of F4 recombinant fusion protein (containing clade B Gag/p24, Pol/RT, Nef and Gag/p17) formulated in AS01 Adjuvant System, and was shown to induc
Externí odkaz:
https://doaj.org/article/a7095b2a8d4e4a7c8d855ef71a5c01ac
Autor:
Pascal Mettens, Roland Gori
Publikováno v:
Revista Latinoamericana de Psicopatologia Fundamental, Vol 3, Iss 3, Pp 46-72
Neste texto busca-se uma teorização do sujeito a partir da psicanálise, do estruturalismo e da noção de pós-modernidade. Os autores propõem-se, aqui, a mostrar como e por que um ocultamento da questão do sujeito incessantemente retorna e cond
Externí odkaz:
https://doaj.org/article/068b53f376e84fb0847cfeb6245d0505
Autor:
Patricia Bourguignon, E. Jane Hughes, Hennie Geldenhuys, Opokua Ofori-Anyinam, Michele van Rooyen, Joe Cohen, Michele Tameris, Philippe Moris, Hassan Mahomed, Lebohang Makhethe, Marie-Ange Demoitié, Gregory D. Hussey, Sebastian Gelderbloem, Anne Bollaerts, Jerald C. Sadoff, Mzwandile Erasmus, Willem A. Hanekom, Anthony Hawkridge, Pascal Mettens, Cheryl L. Day, Nazma Mansoor, Marwou de Kock
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 188:492-502
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide, thus there is an urgent need for novel TB vaccines.We investigated a novel TB vaccine candidate, M72/AS01, in a phase IIa trial of bacille Calmette-Guérin-vaccinated, HIV-uninf
Autor:
Gerald Voss, Nicolas Dumey, Johann Mols, Olga Rovira, Clarisse Lorin, Frédérick Le Goff, Patricia Bourguignon, Pascal Mettens, Frédéric Tangy, Jérémy Silvano, Lawrence Segal, Marguerite Koutsoukos, Danielle Morelle
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology
As a new human immunodeficiency virus type 1 (HIV-1) vaccine approach, the live-attenuated measles virus (MV) Schwarz vaccine strain was genetically engineered to express the F4 antigen (MV1-F4). F4 is a fusion protein comprising HIV-1 antigens p17 a
Autor:
Pascal Mettens
Publikováno v:
Cahiers de psychologie clinique. :59-83
Resume Apres un examen minutieux des textes psychopathologiques du dernier Freud (de 1924 a 1938), l’auteur demontre, outre l’existence de psychoses sexuelles dans la derniere nosographie freudienne, que cette derniere englobe potentiellement tou
Autor:
Peter Probst, Steven G. Reed, Joe Cohen, Pascal Mettens, Yves Lobet, Ajay Bhatia, Hang Fang, Pamela J. Ovendale, Rhea N. Coler, Brenda Barth, Jean-Francois Maisonneuve, Mark R. Alderson
Publikováno v:
FEMS Immunology & Medical Microbiology. 55:258-270
Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection worldwide, with over 91 million cases estimated annually. An effective subunit vaccine against Chlamydia may require a multivalent subunit cocktail of antigen
Autor:
Steven G, Reed, Rhea N, Coler, Wilfried, Dalemans, Wilifred, Dalemans, Esterlina V, Tan, Eduardo C, DeLa Cruz, Randall J, Basaraba, Ian M, Orme, Yasir A W, Skeiky, Mark R, Alderson, Karen D, Cowgill, Jean-Paul, Prieels, Rodolfo M, Abalos, Marie-Claude, Dubois, Joe, Cohen, Pascal, Mettens, Yves, Lobet
Publikováno v:
Proceedings of the National Academy of Sciences. 106:2301-2306
The development of a vaccine for tuberculosis requires a combination of antigens and adjuvants capable of inducing appropriate and long-lasting T cell immunity. We evaluated Mtb72F formulated in AS02A in the cynomolgus monkey model. The vaccine was i
Autor:
Nathalie Garçon, Patrice M. Dubois, Babak Bayat, V. Ann Stewart, Joe Cohen, D. Gray Heppner, Patricia Bourguignon, Marie-Ange Demoitié, Marie-Noelle Renelle Donner, Pascal Mettens
Publikováno v:
Vaccine. 26:1072-1082
Protection against Plasmodium falciparum sporozoite infection can be achieved by vaccination with the recombinant circumsporozoite protein-based vaccine RTS,S formulated with the AS02A Adjuvant System. Since this protection is only partial and wanes
Autor:
M. Gettayacamin, Kosol Yongvanitchit, Joe Cohen, Pascal Mettens, W. R. Ballou, U. Kum-Arb, M. M. Fukuda, Amporn Limsalakpetch, David E. Lanar, D. G. Heppner, V. A. Stewart, Lisa A. Ware, Sathit Pichyangkul
Publikováno v:
Infection and Immunity. 76:229-238
Several lines of evidence suggest that targeting pre-erythrocytic-stage parasites for malaria vaccine development can provide sterile immunity. The objectives of this study were (i) to evaluate preclinically the safety and immunogenicity of a new rec
Autor:
Marie-Ange Demoitié, Maria G. Pau, Patrice M. Dubois, V. Ann Stewart, J. Robert Burge, Shannon McGrath, Babak Bayat, D. Gray Heppner, Pascal Mettens, Marie-Claude Dubois, Gerrit Jan Weverling, Jerome Custers, Jaap Goudsmit, Lisa A. Ware, Joseph P. Shott, David Larson, Michelle Cobb, Joe Cohen
Publikováno v:
Infection and immunity, 75(5), 2283-2290. American Society for Microbiology
The RTS,S/AS02A protein-based vaccine consistently demonstrates significant protection against infection with Plasmodium falciparum malaria and also against clinical malaria and severe disease in children in areas of endemicity. Here we demonstrate w